SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-19-001171
Filing Date
2019-05-22
Accepted
2019-05-22 17:19:16
Documents
1
Period of Report
2019-05-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 4048
  Complete submission text file 0001593968-19-001171.txt   5527
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11455 EL CAMINO REAL, SUITE 310 SAN DIEGO CA 92130
Business Address
Daniels Karen K. (Reporting) CIK: 0001530197 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 19846790